Detailed answers about IMMUNOKINE LIMITED, including incorporation, status, business activity, and accounts information.
When was IMMUNOKINE LIMITED founded?
IMMUNOKINE LIMITED was officially incorporated on 15 June 2020 and is registered under company number 12673199. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IMMUNOKINE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of IMMUNOKINE LIMITED?
IMMUNOKINE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does IMMUNOKINE LIMITED do?
IMMUNOKINE LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is IMMUNOKINE LIMITED's registered address?
The registered office address of IMMUNOKINE LIMITED is MOORCOURT HOUSE, UPPER PENDOCK, MALVERN, ENGLAND, WR13 6JW. This is the official address filed with Companies House for legal and statutory correspondence.
Is IMMUNOKINE LIMITED financially stable?
The most recent accounts for IMMUNOKINE LIMITED were made up to 30 June 2024, filed as DORMANT. Next accounts are due by 31 March 2026.